Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Chronic intestinal disease"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Review
Miscellaneous
Involvement of the cannabinoid system in chronic inflammatory intestinal diseases: opportunities for new therapies
Priscila A. Lima, Bárbara B. Berg, Marina Gomes Miranda e Castor
Intest Res 2022;20(4):392-417.   Published online May 31, 2022
DOI: https://doi.org/10.5217/ir.2021.00160
AbstractAbstract PDFPubReaderePub
The components of the endogenous cannabinoid system are widely expressed in the gastrointestinal tract contributing to local homeostasis. In general, cannabinoids exert inhibitory actions in the gastrointestinal tract, inducing anti-inflammatory, antiemetic, antisecretory, and antiproliferative effects. Therefore, cannabinoids are interesting pharmacological compounds for the treatment of several acute intestinal disorders, such as dysmotility, emesis, and abdominal pain. Likewise, the role of cannabinoids in the treatment of chronic intestinal diseases, such as irritable bowel syndrome and inflammatory bowel disease, is also under investigation. Patients with chronic intestinal inflammatory diseases present impaired quality of life, and mental health issues are commonly associated with long-term chronic diseases. The complex pathophysiology of these diseases contributes to difficulties in diagnosis and, therefore, in the choice of a satisfactory treatment. Thus, this article reviews the involvement of the cannabinoid system in chronic inflammatory diseases that affect the gastrointestinal tract and highlights possible therapeutic approaches related to the use of cannabinoids.

Citations

Citations to this article as recorded by  
  • Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose diet
    Klaudia Sztolsztener, Ewa Harasim-Symbor, Adrian Chabowski, Karolina Konstantynowicz-Nowicka
    Biomedicine & Pharmacotherapy.2024; 178: 117286.     CrossRef
  • Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
    Dinesh Thapa, Leon N. Warne, Marco Falasca
    International Journal of Molecular Sciences.2023; 24(19): 14677.     CrossRef
  • 5,809 View
  • 372 Download
  • 3 Web of Science
  • 2 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP